B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells - PubMed (original) (raw)
B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells
Michelle A Hurchla et al. J Immunol. 2005.
Erratum in
- J Immunol. 2005 May 1;174(9):5884. Gavrielli, Maya [corrected to Gavrieli, Maya]
Abstract
B and T lymphocyte attenuator (BTLA) was initially identified as expressed on Th1 cells and B cells, but recently reported to be expressed by macrophages, dendritic cells, and NK cells as well. To address this discrepancy we generated a panel of BTLA-specific mAbs and characterized BTLA expression under various activation conditions. We report the existence of three distinct BTLA alleles among 23 murine strains, differing both in Ig domain structure and cellular distribution of expression on lymphoid subsets. The BALB/c and MRL/lpr alleles differ at one amino acid residue, but C57BL/6 has nine additional differences and alters the predicted cysteine bonding pattern. The BALB/c BTLA allele is also expressed by B cells, T cells, and dendritic cells, but not macrophages or NK cells. However, C57BL/6 BTLA is expressed on CD11b+ macrophages and NK cells. Finally, in CD4+ T cells, BTLA is expressed most highly following Ag-specific induction of anergy in vivo, and unlike programmed death-1 and CTLA-4, not expressed by CD25+ regulatory T cells. These results clarify discrepancies regarding BTLA expression, suggest that structural and expression polymorphisms be considered when analyzing BTLA in various murine backgrounds, and indicate a possible role in anergic CD4+ T cells.
Similar articles
- Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation.
Hurchla MA, Sedy JR, Murphy KM. Hurchla MA, et al. J Immunol. 2007 May 15;178(10):6073-82. doi: 10.4049/jimmunol.178.10.6073. J Immunol. 2007. PMID: 17475832 - B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function.
Serriari NE, Gondois-Rey F, Guillaume Y, Remmerswaal EB, Pastor S, Messal N, Truneh A, Hirsch I, van Lier RA, Olive D. Serriari NE, et al. J Immunol. 2010 Sep 15;185(6):3140-8. doi: 10.4049/jimmunol.0902487. Epub 2010 Aug 6. J Immunol. 2010. PMID: 20693422 - An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection.
Han P, Goularte OD, Rufner K, Wilkinson B, Kaye J. Han P, et al. J Immunol. 2004 May 15;172(10):5931-9. doi: 10.4049/jimmunol.172.10.5931. J Immunol. 2004. PMID: 15128774 - B and T lymphocyte attenuator suppresses IL-21 production from follicular Th cells and subsequent humoral immune responses.
Kashiwakuma D, Suto A, Hiramatsu Y, Ikeda K, Takatori H, Suzuki K, Kagami S, Hirose K, Watanabe N, Iwamoto I, Nakajima H. Kashiwakuma D, et al. J Immunol. 2010 Sep 1;185(5):2730-6. doi: 10.4049/jimmunol.0903839. Epub 2010 Jul 26. J Immunol. 2010. PMID: 20660710 - BTLA: a new inhibitory receptor with a B7-like ligand.
Carreno BM, Collins M. Carreno BM, et al. Trends Immunol. 2003 Oct;24(10):524-7. doi: 10.1016/j.it.2003.08.005. Trends Immunol. 2003. PMID: 14552835 Review.
Cited by
- Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants.
Adegoke AO, Thangavelu G, Chou TF, Petersen MI, Kakugawa K, May JF, Joannou K, Wang Q, Ellestad KK, Boon L, Bretscher PA, Cheroutre H, Kronenberg M, Baldwin TA, Anderson CC. Adegoke AO, et al. Open Biol. 2024 Oct;14(10):240178. doi: 10.1098/rsob.240178. Epub 2024 Oct 30. Open Biol. 2024. PMID: 39471840 Free PMC article. - Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression.
Costa JP, de Carvalho A, Paiva A, Borges O. Costa JP, et al. Pharmaceuticals (Basel). 2024 Jul 21;17(7):964. doi: 10.3390/ph17070964. Pharmaceuticals (Basel). 2024. PMID: 39065812 Free PMC article. Review. - HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function.
Liu Y, Wang L, Li Y, Zhong C, Wang X, Wang X, Xia Z, Liao J, Huang C, Mao C, Feng Y, Luo C, Mai W, Song H, Li H, Bao L, Chen D, Sheng Y, Zhang H, Wei X, Chen J, Yi W. Liu Y, et al. Cell Oncol (Dordr). 2024 Oct;47(5):1779-1796. doi: 10.1007/s13402-024-00959-1. Epub 2024 May 29. Cell Oncol (Dordr). 2024. PMID: 38809326 - High dimensional proteomic mapping of bone marrow immune characteristics in immune thrombocytopenia.
Liu FQ, Qu QY, Lei Y, Chen Q, Chen YX, Li ML, Sun XY, Wu YJ, Huang QS, Fu HX, Kong Y, Li YY, Wang QF, Huang XJ, Zhang XH. Liu FQ, et al. Sci China Life Sci. 2024 Aug;67(8):1635-1647. doi: 10.1007/s11427-023-2520-4. Epub 2024 Apr 19. Sci China Life Sci. 2024. PMID: 38644444 - Analysis of the immunological markers BTLA, TIM-3, and PD-L1 at the invasion front and tumor center in clear cell renal cell carcinoma.
Stühler V, Alemi B, Rausch S, Stenzl A, Schwab M, Schaeffeler E, Bedke J. Stühler V, et al. World J Urol. 2024 Jan 20;42(1):53. doi: 10.1007/s00345-023-04721-4. World J Urol. 2024. PMID: 38244072
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous